These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31249911)

  • 1. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification.
    Gibson CM; Spyropoulos AC; Cohen AT; Hull RD; Goldhaber SZ; Yusen RD; Hernandez AF; Korjian S; Daaboul Y; Gold A; Harrington RA; Chi G
    TH Open; 2017 Jun; 1(1):e56-e65. PubMed ID: 31249911
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.
    Chi G; Gibson CM; Hernandez AF; Hull RD; Kazmi SHA; Younes A; Walia SS; Pitliya A; Singh A; Kahe F; Kalayci A; Nafee T; Kerneis M; AlKhalfan F; Cohen AT; Harrington RA; Goldhaber SZ
    Am J Med; 2018 Aug; 131(8):972.e1-972.e7. PubMed ID: 29660351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 and finding of vein thrombosis: can IMPROVE and IMPROVEDD scores predict COVID-19 outcomes?
    Greco S; Zenunaj G; Bonsi B; Bella A; Lopreiato M; Luciani F; Pedrini D; Vestita G; Dalla Nora E; Passaro A
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2123-2130. PubMed ID: 33660832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis.
    Spyropoulos AC; Lipardi C; Xu J; Peluso C; Spiro TE; De Sanctis Y; Barnathan ES; Raskob GE
    TH Open; 2020 Jan; 4(1):e59-e65. PubMed ID: 32190813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial.
    Gibson CM; Jennings LK; Chi G; Yee MK; Halaby R; Nafee T; AlKhalfan F; Kerneis M; Korjian S; Daaboul Y; Goldhaber SZ; Hull RD; Hernandez AF; Cohen AT; Harrington RA
    TH Open; 2018 Jan; 2(1):e16-e24. PubMed ID: 31249924
    [No Abstract]   [Full Text] [Related]  

  • 6. Extended Thromboprophylaxis With Betrixaban or Rivaroxaban for Acutely Ill Hospitalized Medical Patients: Meta-Analysis of Prespecified Subgroups.
    Jamil A; Jamil U; Singh K; Khan F; Chi G
    Crit Pathw Cardiol; 2021 Mar; 20(1):16-24. PubMed ID: 32657973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis.
    Chi G; Lee JJ; Jamil A; Gunnam V; Najafi H; Memar Montazerin S; Shojaei F; Marszalek J
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32756383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial.
    Chi G; Gibson CM; Liu Y; Hernandez AF; Hull RD; Cohen AT; Harrington RA; Goldhaber SZ
    Am J Hematol; 2019 Jan; 94(1):21-28. PubMed ID: 30252149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of D-dimer with short-term risk of venous thromboembolism in acutely ill medical patients: A systematic review and meta-analysis.
    Chi G; Lee JJ; Memar Montazerin S; Marszalek J
    Vasc Med; 2022 Oct; 27(5):478-486. PubMed ID: 35913041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer.
    Kumar V; Shaw JR; Key NS; Ilich A; Mallick R; Wells PS; Carrier M
    Oncologist; 2020 Dec; 25(12):1075-1083. PubMed ID: 32969580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial.
    Cohen AT; Spiro TE; Spyropoulos AC; Desanctis YH; Homering M; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Tapson VF; Burton P;
    J Thromb Haemost; 2014 Apr; 12(4):479-87. PubMed ID: 24460645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
    Raskob GE; Spyropoulos AC; Zrubek J; Ageno W; Albers G; Elliott CG; Halperin J; Haskell L; Hiatt WR; Maynard GA; Peters G; Spiro T; Steg PG; Suh EY; Weitz JI
    Thromb Haemost; 2016 Jun; 115(6):1240-8. PubMed ID: 26842902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial.
    Chi G; Violi F; Pignatelli P; Vestri A; Spagnoli A; Loffredo L; Hernandez AF; Hull RD; Cohen AT; Harrington RA; Goldhaber SZ; Gibson CM
    J Thromb Thrombolysis; 2023 Feb; 55(2):211-221. PubMed ID: 36566304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels.
    Weinberg I; Fernández-Capitán C; Quintana-Díaz M; Demelo-Rodriguez P; García de Casasola G; Fidalgo Á; Maria Suriñach J; Díaz-Pedroche C; Galeano-Valle F; Siniscalchi C; Visonà A; Bikdeli B; Jiménez D; Monreal M;
    Thromb Update; 2021; 2():100029. PubMed ID: 38620598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New paradigms in venous thromboprophylaxis of medically ill patients.
    Spyropoulos AC; Raskob GE
    Thromb Haemost; 2017 Aug; 117(9):1662-1670. PubMed ID: 28640324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of D-dimer testing for venous thrombosis recurrence risk stratification: is this a useful test in the real world?
    Wang J; Tacey M; Ho P
    J Thromb Thrombolysis; 2020 May; 49(4):562-571. PubMed ID: 32253709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
    Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
    Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
    Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
    J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.